Relievant Medsystems Announces New Vertebrogenic Low Back Pain ICD-10 Diagnosis Code
September 29, 2021 09:30 ET
|
Relievant Medsystems, Inc.
BOSTON, Sept. 29, 2021 (GLOBE NEWSWIRE) -- NASS 36th ANNUAL MEETING - Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today...
Relievant Medsystems Announces Appointment of Dave Amerson to Board of Directors
July 01, 2021 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, July 01, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the...
Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Showing Sustained Relief from Chronic Low Back Pain 12 Months Post-Procedure
June 16, 2021 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, June 16, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 12-month...
UPDATE -- Relievant Medsystems Names Tyler Binney President and CEO
May 10, 2021 10:51 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, May 10, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the...
Relievant Medsystems Launches Intracept.com Patient Education Website
January 12, 2021 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the launch of...
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
October 29, 2020 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), announced today the...
Relievant Announces Positive 12-Month Intracept Effectiveness Study Results From Community Based Practices
October 22, 2020 09:30 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the North...
Relievant Announces Publication of 5-Year Data Demonstrating Long Term Clinical Benefits of the Intracept Procedure in Chronic Low Back Pain Patients
June 08, 2020 10:15 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced European...
Relievant Announces Publication of Positive Results from Multi-Center Study of the Intracept® Procedure in Real-world Setting for Patients with Chronic Low Back Pain
August 27, 2019 09:15 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the...
Relievant Announces Publication of Level I INTRACEPT Study
June 25, 2019 09:15 ET
|
Relievant Medsystems, Inc.
MINNEAPOLIS, June 25, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company focused on transforming the treatment of Chronic Low Back Pain (CLBP), today announced...